NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIA E-045-2012-0-US-04 THIO COMPOUNDS US DIV 15/457,156 10220028 Issued PDF
NIAID E-118-2016-0-PCT-02 Live Attenuated Zika Virus Vaccine PCT PCT PCT/US2017/021989 Expired
NIAID E-118-2016-0-CO-07 Live Attenuated Zika Virus Vaccine CO National Stage NC2018/0010874 Abandoned
NIAID E-118-2016-0-CN-06 Live Attenuated Zika Virus Vaccine CN National Stage 201780028836.4 Abandoned
NIAID E-118-2016-0-JP-10 Live Attenuated Zika Virus Vaccine JP National Stage 2018-547931 Abandoned
NIAID E-118-2016-0-IN-09 Live Attenuated Zika Virus Vaccine IN National Stage 201817036778 Abandoned
NIAID E-118-2016-0-MX-12 Live Attenuated Zika Virus Vaccine MX National Stage MX/A/2018/010958 Abandoned
NIAID E-118-2016-0-CA-05 Live Attenuated Zika Virus Vaccine CA National Stage 3016697 Abandoned
NIAID E-135-2010-0-US-06 GENETICALLY STABLE LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS VACCINE AND ITS PRODUCTION US DIV 15/455,438 10307476 Issued PDF
NHLBI E-165-2014-1-US-02 LELENTIVIRAL VECTOR FOR TREATING HEMOGLOBIN DISORDERSNTIVIRAL VECTOR FOR TREATING HEMOGLOBIN DISORDERS US National Stage 15/510,014 10543257 Issued PDF
NCI E-056-2011-0-US-20 YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS US CON 15/454,176 10363294 Issued PDF
NIAID E-112-2016-0-PCT-02 Use of CD300b Antagonists to Treat Sepsis and Septic Shock PCT PCT PCT/US2017/021654 Expired
NIAID E-102-2016-0-PCT-02 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE PCT PCT PCT/US2017/021573 Expired
NIDA E-053-2016-1-AU-05 Novel Dopamine D3 Receptor Selective Anatgonists/Partial Agonists with High Affinity and Metabolic Stability for Treatment of Neuropsychiatric Disorders AU National Stage 2017233716 Issued
NIDA E-053-2016-1-PCT-01 Novel Dopamine D3 Receptor Selective Anatgonists/Partial Agonists with High Affinity and Metabolic Stability for Treatment of Neuropsychiatric Disorders PCT PCT COMB PCT/US2017/021328 Expired
NCI E-117-2011-0-JP-34 Recombinant Immunotoxin Targeting Mesothelin JP DIV 2017-043879 Pending
NCI E-217-2011-0-US-04 GENETIC MARKER FOR PREDICTING PROGNOSIS IN PATIENTS INFECTED WITH HEPATITIS C VIRUS US CON 15/453,903 Abandoned
NIDA E-053-2016-1-CA-02 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF CA National Stage 3017342 Pending
NIDCD E-043-2016-0-CN-03 MICRORNAS AND METHODS OF THEIR USE CN National Stage 201780027750.X Issued
NIDCD E-043-2016-0-PCT-02 MICRORNAS AND METHODS OF THEIR USE PCT PCT PCT/US2017/021178 Expired
NIDCD E-043-2016-0-JP-06 MICRORNAS AND METHODS OF THEIR USE JP National Stage 2018-547943 Issued
NHGRI E-044-2013-0-JP-08 Methods For Treating Progeroid Laminopathies Using Oligonucleotide Analogues Targeting Human Lamin JP DIV 2017-41744 Issued
NCI E-148-2011-0-US-12 ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III CHIMERIC ANTIGEN RECEPTORS AND USE OF SAME FOR THE TREATMENT OF CANCER US DIV 15/448,707 1057-02-14 Issued PDF
NIAID E-178-2014-2-US-02 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE US National Stage 15/508,885 10400015 Issued PDF
NICHD E-249-2008-0-US-04 PHANTOM FOR DIFFUSION MRI IMAGING US CON 15/448,760 10078124 Issued PDF
NIAID E-076-2015-4-MX-14 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION MX National Stage MX/a/2017/002889 Pending
NIAID E-076-2015-5-US-20 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSES US National Stage 15/508,288 Pending
NHGRI E-282-2012-2-PCT-02 Cannabinoid Receptor Mediating Compounds PCT PCT PCT/US2017/020250 Expired
CC E-046-2016-0-PCT-02 Category Discovery And Image Auto-Annotation Via Looped Deep Pseudo-Task Optimization PCT PCT PCT/US2017/020185 Expired
CC E-045-2016-0-PCT-02 Recurrent Neural Feedback Model For Automated Image Annotation PCT PCT PCT/US2017/020183 Expired
NIAID E-076-2015-4-US-20 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION US National Stage 15/507,975 Pending
NHGRI E-282-2012-2-CN-03 Cannabinoid Receptor Mediating Compounds CN National Stage 201780011869.8 Pending
NHGRI E-282-2012-2-EP-04 Cannabinoid Receptor Mediating Compounds EP National Stage 17711443.6 Pending
NCI E-094-2004-0-US-11 Pharmacodynamic Assays US CON 15/445,975 Abandoned
NCI E-257-2014-0-US-03 Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis US National Stage 15/507,316 Abandoned
NIAID E-076-2015-4-MY-15 METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST FILOVIRUS INFECTION MY National Stage PI2017700702 Pending
NIAID E-106-2016-0-PCT-02 PEPTIDE VACCINE FORMULATIONS AND USE THEREOF FOR INDUCING AN IMMUNE RESPONSE PCT PCT PCT/US2017/019748 Expired
NHLBI E-108-2010-0-US-05 Methods and Devices for Transcatheter Cerclage Annuloplasty US DIV 15/442,636 10751179 Issued PDF
NCI E-069-2016-0-US-05 Synergistic Therapeutic Antitumor Effect Of HMGN1 With Other Antitumor Treatments US National Stage 16/313,454 11266746 Issued PDF
NEI E-164-2014-0-US-03 METHODS AND COMPOSITIONS FOR TREATING LEBER CONGENITAL AMAUROSIS US National Stage 15/506,323 10351844 Issued PDF
NCI E-069-2016-0-PCT-02 Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments PCT PCT PCT/US17/019342 Expired
NCI E-069-2016-0-CA-04 Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments CA National Stage 3028654 Pending
NCI E-018-2017-0-IN-01 Graphene Oxide-Polycarbonate Track-Etched Nanosieve Platform For Sensitive Detection Of Human Immunodeficiency Virus Envelope Glycoprotein IN ORD 201711002764 Pending
NCI E-069-2016-0-AU-03 Therapeutic Antitumor Combination of a TLR4 Ligand With Other Treatments AU National Stage 2017289450 Pending
NLM E-107-2010-2-US-12 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/440,815 10323269 Issued PDF
NLM E-107-2010-2-US-10 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/440,284 10031131 Issued PDF
NLM E-107-2010-2-US-07 DETECTION OF 5-HYDROXYMETHYLCYTOSINE BY GLYCOSYLATION US CON 15/440,408 9816986 Issued PDF
NLM E-107-2010-2-US-09 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/440,822 Abandoned
NLM E-107-2010-2-US-11 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/440,319 Abandoned
NLM E-107-2010-2-US-08 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/440,424 Abandoned